Uraemia progression in chronic kidney disease stages 3-5 is not constant

Nephron - Clinical Practice

Volumn 118, Issue 4, 2011, Pages

  Heaf, James Goya ^a,c   Mortensen, Leif Spange ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNI C   (Denmark)

^c NONE   (Denmark)

Author keywords

Creatinine clearance; Glomerular filtration rate; Hyperfiltration; Uraemia

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION NEPHROPATHY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; UREMIA;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; TIME FACTORS; UREMIA;

EID: 79851512390     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000323391     Document Type: Article

References (26)

1. Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A: Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet 1991; 337: 1299-1304.
2. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW: Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006; 354: 131-140. (Pubitemid 43076710)
3. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and bloodpressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-884. (Pubitemid 24094966)
4. Lemos PA, Serruys PW, de Feyter P, Mercado NF, Goedhart D, Saia F, Arampatzis CA, Soares PR, Ciccone M, Arquati M, Cortellaro M, Rutsch W, Legrand V: Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy). Am J Cardiol 2005; 95: 445-451. (Pubitemid 40247536)
5. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945. (Pubitemid 26114159)
6. Kamper AL, Strandgaard S, Leyssac PP: Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria. Nephrol Dial Transplant 1995; 10: 1182-1188.
7. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 1997; 63:S124-S127. (Pubitemid 28020450)
8. Luyckx VA, Brenner BM: Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 2005; 97:S68-S77.
9. Heaf JG: Algorithm for optimal dialysis access timing. Clin Nephrol 2007; 67: 96-104.
10. Levey AS, Bosch JP, Lewis JB, Greene T: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
11. Levey AS, Gassman J, Hall PM, Walker WG: Assessing the progression of renal disease in clinical studies: Effects of duration of followup and regression to the mean. J Am Soc Nephrol 1991; 1: 1087-1094
12. Morrison AB, Howard RNM: The functional capacity of hypertrophied nephrons: Effect of partial nephrectomy on the clearance of inulin and PAH in the rat. J Exp Med 1966; 123: 829-844.
13. Ots M, Troy JL, Rennke HG, Mackenzie HS, Brenner BM: Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease. Nephrol Dial Transplant 2004; 19: 337-341. (Pubitemid 38195981)
14. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12: 1315-1325. (Pubitemid 32472647)
15. Foley RN, Ibrahim HN: Long-term outcomes of kidney donors. Curr Opin Nephrol Hypertens 2010; 19: 129-133.
16. Virga G, La Milia V, Russo R, Bonfante L, Cara M, Nordio M: Comparison between creatinine-based equations for estimating total creatinine clearance in peritoneal dialysis: A multicentre study. Nephrol Dial Transplant 2010; 25: 262-269.
17. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G: In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol 1999; 10: 997-1006. (Pubitemid 29203086)
18. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393. (Pubitemid 36159355)
19. Massy ZA, Nguyen Khoa T, Lacour B, Descamps-Latscha B, Man NK, Jungers P: Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 1999; 14: 2392-2397. (Pubitemid 29462477)
20. Wright JT Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 2002; 288: 2421-2431. (Pubitemid 35340538)
21. Coggins CH, Breyer Lewis J, Caggiula AW, Castaldo LS, Klahr S, Wang SR: Differences between women and men with chronic renal disease. Nephrol Dial Transplant 1998; 13: 1430-1437. (Pubitemid 28254317)
22. Heaf JG, Løkkegaard H, Larsen S: The Epidemiology and Prognosis of Glomerulonephritis in Denmark 1985-97. Nephrol Dial Transplant 1999; 14: 1889-1897. (Pubitemid 29358884)
23. De Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM: Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 2009; 20: 2075-2084.
24. Heaf JG, Ladefoged J: Hyperfiltration, creatinine clearance and chronic graft loss. Clin Transplant 1998; 12: 11-18. (Pubitemid 28112320)
25. Lewis J, Greene T, Appel L, Contrereas G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT: A comparison of iothalamate-GFR and serum creatinine-based outcomes: Acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 2004; 15: 3175-3183. (Pubitemid 39578850)
26. Kacso I, Gherman M, Mazouz H, Ghazali A, el Esper N, Moriniére P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A: Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis (in French). Nephrologie 1999; 20: 19-28. (Pubitemid 29091028)